Home

CHRISTOPHERD T GUIFFRE

CIK 1219021 · CFO, COO, Treas., & Asst. Sec. · last filed 2023-02-17

CHRISTOPHERD T GUIFFRE is a CFO, COO, Treas., & Asst. Sec. who has filed 26 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for PEARW, was dated Feb 17, 2023. Across all open-market trades the lifetime net is −$1.0M, making them a net seller over the disclosed history. 42 SEC filings were submitted jointly with CUBIST PHARMACEUTICALS INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

26

Lifetime Open-Market Net

-$1.02M

Filer Profile

Reported Address
65 HAYDEN AVE
LEXINGTON, MA 02421
Related Filers
CUBIST PHARMACEUTICALS INC — 42 joint filings, latest 2008-04-02
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Pear Therapeutics, Inc. (PEARW) Delisted CFO, COO, Treas., & Asst. Sec. 29,960 $0.01 $177 -$22.1K 5 2023-02-17
Dare Bioscience, Inc. (CERU) Delisted Chief Executive Officer 1,249 — — $0 8 2017-01-09
CUBIST PHARMACEUTICALS INC (CBST) Delisted Senior Vice President 5,359 — — -$1.00M 13 2008-04-02

Recent Filings

26 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-02-17 Pear Therapeutics, Inc. (PEARW) Delisted Grant (A) — $0 EDGAR
2023-01-24 Pear Therapeutics, Inc. (PEARW) Delisted Sell (S) −19,540 -$22.1K EDGAR
2023-01-18 Pear Therapeutics, Inc. (PEARW) Delisted Exer (M) +49,500 $0 EDGAR
2022-02-18 Pear Therapeutics, Inc. (PEARW) Delisted Grant (A) — $0 EDGAR
2021-12-07 Pear Therapeutics, Inc. (PEARW) Delisted Grant (A) — $0 EDGAR
2017-01-09 Dare Bioscience, Inc. (CERU) Delisted Grant (A) — $0 EDGAR
2017-01-05 Dare Bioscience, Inc. (CERU) Delisted Grant (A) +5,733 $3.4K EDGAR
2016-07-08 Dare Bioscience, Inc. (CERU) Delisted Grant (A) +3,999 $7.2K EDGAR
2016-01-07 Dare Bioscience, Inc. (CERU) Delisted Grant (A) +2,757 $6.6K EDGAR
2016-01-07 Dare Bioscience, Inc. (CERU) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 26
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.